Objectives-To study the occurrence of mycoplasmas and ureaplasmas in patients with hypogammaglobulinaemia and the relationship of these micro-organisms to septic arthritis. Methods-Over a period ofabout 20 years, 53 men and 38 women with hypogammaglobulinaemia, most of whom were less than 50 years old, were examined clinically and microbiologically. Mycoplasmas and ureaplasmas were sought in the throat, urogenital tract and joints by standard cultural methods, although not consistently in the three sites of all patients.
Results-Arginine-hydrolysing mycoplasmas and ureaplasmas occurred with similar frequency in the sputum/throat of the hypogammaglobulinaemic patients, but no more often than might be expected in immunocompetent patients. Ureaplasmas, however, dominated in the urogenital tracts of both men and women, being found in 75% of vaginal specimens. Arginine-hydrolysing mycoplasmas occurred two to six times more frequently and ureaplasmas two to three times more frequently in urine specimens from hypogammaglobulinaemic patients than they did in such specimens from sex-and agematched non-venereal disease, hospital patients or healthy subjects; these differences were statistically significant (p< 0.05). Enhanced mucosal colonisation probably increases the chance of spread to distant sites, such as the joints. Of the 91 patients, 21 (23%) had septic arthritis involving one or more joints. Mycoplasmas and/or ureaplasmas, but not bacteria, were isolated from the joints of eight (38%) of these patients. However, dissemination to joints apparently had not occurred in some despite the opportunity by virtue of mycoplasmal or ureaplasmal colonisation at a mucosal site. Sometimes antibiotic therapy failed clinically, and microbiologically and recommendations for management are outlined. previously. '5 In brief, liquid medium contained 70% PPLO broth (Difco) to which was added 10% yeast extract (25% w/v), 20% horse serum, 105 iu of penicillin, 0-05% thallium acetate and 0-002% phenol red. To this medium was added one of the following substrates and the pH adjusted as indicated to provide three separate media for the attempted isolation of glucose-fermenting and arginine- The prevalence of both mycoplasmas and ureaplasmas in the urogenital tract of the hypogammaglobulinaemic patients, as judged by their occurrence in urine specimens, was similar in both men and women (table 2) , and ureaplasmas were detected at least twice as often as the arginine-hydrolysing mycoplasmas. The dominance of ureaplasmas was seen also in swab specimens taken from the male urethra, where testing of urethral swabs proved to be about as sensitive as testing urine specimens. In contrast, in women, vaginal specimens, which contained ureaplasmas more frequently than arginine-hydrolysing mycoplasmas, were positive more often than the urine specimens. tUreaplasmas.
Conclusions-Hypogammaglobulinaemic

COMPARISON OF URINE FINDINGS FOR HYPOGAMMAGLOBULINAEMIC AND IMMUNOCOMPETENT PATIENTS
The results of culturing urines from men and women with hypogammaglobulinaemia are compared with the results, reported previously,'8 of testing urines from a non-venereal disease, hospital patient group, and from a healthy group (table 3) . The argininehydrolysing mycoplasmas occurred two to six times more frequently and the ureaplasmas two to three times more frequently in the hypogammaglobulinaemic patients than they did in the other two groups, differences which were statistically significant (p < 0-05).
MYCOPLASMAS AND UREAPLASMAS ISOLATED FROM JOINTS
Of the 91 hypogammaglobulinaemic patients examined, 21 (23%) (12 men and 9 women) had septic arthritis involving one or more joints in which there were polymorphonuclear leucocytes in the synovial fluid, that is a septic arthritis. Neither aerobic nor anaerobic bacteria were detected in the specimens from tUreaplasmas. **Hypogammaglobulinaemic. these joints. However, mycoplasmas and/or ureaplasmas were isolated from the joints of eight (38%) of the arthritic patients; the details are shown in table 4. Ureaplasmas were recovered most frequently, occurring in half of the patients who had organisms in the joints.
MYCOPLASMAS AND/OR UREAPLASMAS AT OTHER ANATOMICAL SITES OF JOINT-POSITIVE AND -NEGATIVE PATIENTS
Of the eight patients whose joint specimens were positive for mycoplasmas and/or ureaplasmas, seven were sampled from one or more other sites (throat, urethra, vagina); of these, five (71%) were positive, the organisms corresponding to those found in the joints. Of the 13 patients whose joint specimens were negative, seven were sampled from one or more other sites; of these, three (43%) were positive. In comparison, of 41 men with hypogammaglobulinaemia who did not have arthritis, mycoplasmas and/or ureaplasmas were isolated from one or more non-articular sites of 15 (37%), and of 29 such women, these microorganisms were isolated from one or more nonarticular sites of 13 (45%).
The occurrence of these micro-organisms at the various anatomical sites examined in this study is summarised in table 5.
Discussion
Since previous work had shown that mycoplasmas and/or ureaplasmas were a cause of septic arthritis in hypogammaglobulinaemic patients, it was of interest to analyse all the cases seen and determine the extent to which these micro-organisms existed in the probable primary sites of infection, that is, the respiratory and/or urogenital tracts from which they were able to disseminate to the joint(s). It should be appreciated that this was not a planned prospective study in which specimens were taken from all possible sites each time a patient was seen over the 20-year period. The data therefore are fragmentary, but nevertheless informative and are summarised in table 5 . The tendency for mycoplasmas to be found more often in sputum than throat specimens may be due to inadequate swabbing. Overall, the prevalence of argininehydrolysing mycoplasmas in the sputum and throat was certainly no greater than might be expected in immunocompetent patients. 19 Conversely, the prevalence of ureaplasmas was greater, but the results were in keeping with those of others20 who have examined the respiratory tract of hypogammaglobulinaemic patients. Ureaplasmas were found by us even more frequently in the urogenital tract of such patients. These organisms, and mycoplasmas, were particularly common in women. It is likely that the vagina is the preferential site of colonisation and that many of the organisms recovered from the urine resulted from contamination of the specimens from the vagina.
It should be emphasised that the samples from the hypogammaglobulinaemic patients had been collected over a period of 20 years and that the sexual orientation, number of lifetime sexual partners and other demographic details of these patients were unknown. We compared the results of mycoplasmal isolation from the urine of these patients with those, reported previously,'8 of similar isolation attempts, over a short period, from groups of sex-and age-matched immunocompetent individuals for whom other demographic details were lacking. It is difficult therefore to know exactly how valid the comparison is, but on this basis, the mycoplasmas and ureaplasmas occurred apparently much more frequently at mucosal sites in the hypogammaglobulinaemic patients. The absence of protective antibody at the mucosal surfaces2' could account for increased susceptibility to colonisation. Of course, more frequent colonisation at mucosal sites in the hypogammaglobulinaemic patients than in immunocompetent individuals, often with large numbers of organisms, would increase the opportunity for organisms to disseminate to distant sites, such as the joints and even bone.22
There is also a suggestion that patients who developed arthritis had mycoplasmas and/or ureaplasmas at a non-articular site more often than did those who did not develop arthritis, but the number of patients examined is too small to be sure of this point. The absence of, or reduced levels of antibody in the hypogammaglobulinaemic patients is also a factor in the enhanced ability of the organisms to spread. Mycoplasmas and/or ureaplasmas were detected by us in the joints of about twofifths of such patients who were examined when they had an acute attack of septic arthritis. None of them had a bacterial infection of the joint. Whether any of the apparently mycoplasma-or ureaplasmanegative arthritides were due to these microorganisms (our culture attempts having failed perhaps due to previous antibiotic therapy) is a moot point. Almost half of these patients appear to have had the organisms colonising a mucosal surface at the time they had arthritis. In addition, some disease may have been due to mycoplasmas which we did not seek. Those antibiotic in an attempt to counter this effect. In the recalcitrant cases, clinical improvement appeared to be brought about by administration of antiserum prepared specifically against the mycoplasma in question.'0 Our experience leads us to suggest that: (1) the likelihood of mycoplasmal involvement should always be considered in arthritis developing in hypogammaglobulinaemic patients, particularly when attempts to isolate bacteria from synovial fluids and/or tissues by routine bacteriological methods have failed; (2) the isolate should be tested immediately against a wide range of antibiotics in vitro; (3) the most inhibitory antibiotic should be given as soon as possible by the most appropriate route (intravenously, if possible); (4) such therapy should be prolonged and terminated only if there is no reasonably rapid clinical and/or microbiological response, and (5) thought should be given to the administration of a specific antiserum, perhaps together with antibiotics, in those cases that do not respond.
Gelfand2" has recommended the use of intravenous immunoglobulin with a high titre of antibody for eradication or prevention of infection in hypogammaglobulinaemic patients.
The data presented here were collected from patients with hypogammaglobulinaemia, but these organisms occur also in those undergoing immunosuppressive chemotherapy29 30 and our recommendations for therapy could also prove valuable for these patients. 
